vs
Karat Packaging Inc.（KRT）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是Karat Packaging Inc.的1.8倍（$207.3M vs $115.6M），Karat Packaging Inc.净利率更高（5.9% vs -62.0%，领先67.9%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 13.7%），Karat Packaging Inc.自由现金流更多（$15.1M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 10.0%）
Karat Packaging Inc.是专业一次性餐饮包装产品生产商及分销商，产品涵盖纸塑杯、食品容器、餐具、杯盖及定制品牌包装方案，主要服务北美地区的连锁餐厅、咖啡馆、餐饮服务商及零售食品客户。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
KRT vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $115.6M | $207.3M |
| 净利润 | $6.8M | $-128.6M |
| 毛利率 | 34.0% | — |
| 营业利润率 | 7.3% | -54.7% |
| 净利率 | 5.9% | -62.0% |
| 营收同比 | 13.7% | 25.9% |
| 净利润同比 | 21.3% | 3.5% |
| 每股收益（稀释后） | $0.34 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $115.6M | $207.3M | ||
| Q3 25 | $124.5M | $159.9M | ||
| Q2 25 | $124.0M | $166.5M | ||
| Q1 25 | $103.6M | $139.3M | ||
| Q4 24 | $101.6M | $164.6M | ||
| Q3 24 | $112.8M | $139.5M | ||
| Q2 24 | $112.6M | $147.0M | ||
| Q1 24 | $95.6M | $108.8M |
| Q4 25 | $6.8M | $-128.6M | ||
| Q3 25 | $7.3M | $-180.4M | ||
| Q2 25 | $10.9M | $-115.0M | ||
| Q1 25 | $6.4M | $-151.1M | ||
| Q4 24 | $5.6M | $-133.2M | ||
| Q3 24 | $9.1M | $-133.5M | ||
| Q2 24 | $9.1M | $-131.6M | ||
| Q1 24 | $6.2M | $-170.7M |
| Q4 25 | 34.0% | — | ||
| Q3 25 | 34.5% | — | ||
| Q2 25 | 39.6% | — | ||
| Q1 25 | 39.3% | — | ||
| Q4 24 | 39.2% | — | ||
| Q3 24 | 38.6% | — | ||
| Q2 24 | 38.5% | — | ||
| Q1 24 | 39.3% | — |
| Q4 25 | 7.3% | -54.7% | ||
| Q3 25 | 6.9% | -106.9% | ||
| Q2 25 | 13.3% | -64.8% | ||
| Q1 25 | 7.5% | -102.6% | ||
| Q4 24 | 7.2% | -74.3% | ||
| Q3 24 | 10.0% | -94.6% | ||
| Q2 24 | 9.9% | -79.1% | ||
| Q1 24 | 8.4% | -151.9% |
| Q4 25 | 5.9% | -62.0% | ||
| Q3 25 | 5.9% | -112.8% | ||
| Q2 25 | 8.8% | -69.0% | ||
| Q1 25 | 6.2% | -108.5% | ||
| Q4 24 | 5.5% | -80.9% | ||
| Q3 24 | 8.1% | -95.7% | ||
| Q2 24 | 8.1% | -89.5% | ||
| Q1 24 | 6.4% | -156.8% |
| Q4 25 | $0.34 | $-1.28 | ||
| Q3 25 | $0.36 | $-1.81 | ||
| Q2 25 | $0.54 | $-1.17 | ||
| Q1 25 | $0.32 | $-1.57 | ||
| Q4 24 | $0.28 | $-1.34 | ||
| Q3 24 | $0.45 | $-1.40 | ||
| Q2 24 | $0.45 | $-1.52 | ||
| Q1 24 | $0.31 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $37.9M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $149.4M | $-80.0M |
| 总资产 | $287.7M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $37.9M | $421.0M | ||
| Q3 25 | $44.0M | $202.5M | ||
| Q2 25 | $57.0M | $176.3M | ||
| Q1 25 | $56.3M | $127.1M | ||
| Q4 24 | $59.9M | $174.0M | ||
| Q3 24 | $60.4M | $150.6M | ||
| Q2 24 | $52.1M | $480.7M | ||
| Q1 24 | $46.7M | $112.3M |
| Q4 25 | $149.4M | $-80.0M | ||
| Q3 25 | $154.5M | $9.2M | ||
| Q2 25 | $155.8M | $151.3M | ||
| Q1 25 | $153.3M | $144.2M | ||
| Q4 24 | $155.6M | $255.0M | ||
| Q3 24 | $157.3M | $346.8M | ||
| Q2 24 | $157.7M | $432.4M | ||
| Q1 24 | $154.4M | $140.3M |
| Q4 25 | $287.7M | $1.5B | ||
| Q3 25 | $302.8M | $1.2B | ||
| Q2 25 | $321.0M | $1.3B | ||
| Q1 25 | $312.2M | $1.3B | ||
| Q4 24 | $294.5M | $1.5B | ||
| Q3 24 | $306.8M | $1.5B | ||
| Q2 24 | $310.7M | $1.6B | ||
| Q1 24 | $279.0M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $15.4M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $15.1M | $-100.8M |
| 自由现金流率自由现金流/营收 | 13.1% | -48.6% |
| 资本支出强度资本支出/营收 | 0.2% | 0.5% |
| 现金转化率经营现金流/净利润 | 2.26× | — |
| 过去12个月自由现金流最近4个季度 | $33.1M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $15.4M | $-99.8M | ||
| Q3 25 | $982.0K | $-91.4M | ||
| Q2 25 | $9.8M | $-108.3M | ||
| Q1 25 | $7.7M | $-166.5M | ||
| Q4 24 | $8.3M | $-79.3M | ||
| Q3 24 | $19.5M | $-67.0M | ||
| Q2 24 | $13.7M | $-77.0M | ||
| Q1 24 | $6.6M | $-190.7M |
| Q4 25 | $15.1M | $-100.8M | ||
| Q3 25 | $736.0K | $-92.7M | ||
| Q2 25 | $9.6M | $-110.7M | ||
| Q1 25 | $7.6M | $-167.8M | ||
| Q4 24 | $8.0M | $-79.5M | ||
| Q3 24 | $19.2M | $-68.6M | ||
| Q2 24 | $13.4M | $-79.0M | ||
| Q1 24 | $6.4M | $-193.9M |
| Q4 25 | 13.1% | -48.6% | ||
| Q3 25 | 0.6% | -58.0% | ||
| Q2 25 | 7.7% | -66.5% | ||
| Q1 25 | 7.4% | -120.5% | ||
| Q4 24 | 7.9% | -48.3% | ||
| Q3 24 | 17.0% | -49.2% | ||
| Q2 24 | 11.9% | -53.7% | ||
| Q1 24 | 6.7% | -178.2% |
| Q4 25 | 0.2% | 0.5% | ||
| Q3 25 | 0.2% | 0.8% | ||
| Q2 25 | 0.1% | 1.5% | ||
| Q1 25 | 0.1% | 1.0% | ||
| Q4 24 | 0.2% | 0.1% | ||
| Q3 24 | 0.3% | 1.2% | ||
| Q2 24 | 0.2% | 1.4% | ||
| Q1 24 | 0.2% | 3.0% |
| Q4 25 | 2.26× | — | ||
| Q3 25 | 0.13× | — | ||
| Q2 25 | 0.89× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | 1.47× | — | ||
| Q3 24 | 2.14× | — | ||
| Q2 24 | 1.50× | — | ||
| Q1 24 | 1.06× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KRT
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
